iRhythm Technologies
About iRhythm Technologies
iRhythm Technologies is a leading digital healthcare company at the forefront of cardiac monitoring solutions, leveraging advanced AI and machine learning. The company specializes in developing wearable biosensor devices, most notably the Zio® ECG monitor, which offers a discreet and patient-friendly approach to continuous, long-term cardiac monitoring for up to 14 days. This innovative service is designed to improve the detection and management of various cardiac arrhythmias.
For physicians, the iRhythm monitoring service provides a comprehensive end-to-end solution. It integrates an FDA-cleared AI with a deep-learned algorithm, clinically validated to be as accurate as expert cardiologists in detecting 13 classes of arrhythmias. The platform distills millions of heartbeats into clinically actionable information, generating physician-ready reports often reviewed by certified cardiographic technicians. This streamlined process aims to expedite diagnosis, facilitate informed referral decisions, and enhance the overall patient experience through comfortable wear and reduced retesting, ultimately transforming cardiac care by delivering better data, better insights, and better health.
Focus Areas
Business Intelligence
| Key Investors | Novo, Norwest Venture Partners (NVP), New Leaf Venture Partners, Kaiser Permanente Ventures, St. Jude Medical, Mohr Davidow Ventures, Synergy Life Science Partners, Stanford University |
| Partnerships | Epic (EHR integration), Verily (Zio Watch, AFib solutions), Lucem Health (predictive AI for early arrhythmia detection), BioIntelliSense (multiparameter sensor technology) |
| Technology | Zio® ECG monitor (wearable biosensor), cloud-based data analytics, proprietary deep-learned AI algorithms, ZioSuite® portal, MyZio® app, EHR integration, developing a multivitals platform |
| FDA Clearances | At least 4 distinct FDA 510(k) clearances/updates, including for Zio monitor design and AI capabilities (May 2021), the ZEUS System for Zio Watch (July 2022), and Zio AT device design updates (October 2024 and November 2024). cleared products (estimated) |
What Physicians Need to Know
For physicians, iRhythm Technologies offers a powerful toolset for accurate and timely cardiac arrhythmia diagnosis. The long-term continuous monitoring capabilities (up to 14 days) significantly increase the chances of detecting intermittent arrhythmias that might be missed by shorter-term methods, leading to a higher diagnostic yield and reduced need for retesting. The FDA-cleared deep-learned AI, combined with expert human review, provides highly accurate and actionable end-of-wear reports with 99% physician agreement, fostering diagnostic confidence. The patient-centric design of the Zio patch ensures high patient compliance, leading to more complete and reliable data. Furthermore, the end-to-end service, including seamless EHR integration and the ZioSuite portal, streamlines workflow, reduces administrative burden, and allows physicians to focus more on patient care and less on data management. This enables primary care physicians to efficiently assess patients for potential arrhythmias, expediting time to diagnosis and treatment plans, and supporting value-based care initiatives by improving outcomes and potentially reducing healthcare costs.
iRhythm's Zio service supports seamless integration into existing healthcare workflows through HL7-based EHR integration and Single Sign-On (SSO) via SAML. This helps reduce staff burden, automate processes, and accelerate patient care pathways.
What the Web Says
iRhythm Technologies is a digital healthcare company primarily known for its Zio cardiac monitoring solutions. Product reviews generally highlight the Zio patch's ease of use, comfort, and effectiveness in detecting arrhythmias over extended periods compared to traditional Holter monitors. However, some users report issues with adhesive causing skin irritation and the device detaching. Company and employer reviews are mixed, with some employees praising the culture, benefits, and opportunities for professional development, while others express concerns about management, work-life balance, compensation, and a perceived negative shift in company culture.
Overall: MixedStrengths
- Zio patch is easy to use and comfortable for patients.
- Extended wear time (up to 14 days) increases arrhythmia detection rates.
- Water-resistant and unobtrusive design improves patient compliance.
- Provides comprehensive reports for physicians, often preventing the need for repeat testing.
- Some employees report good benefits, competitive pay, and opportunities for professional development.
- Positive feedback on teamwork and supportive coworkers in some departments.
Limitations
- Adhesive can cause skin irritation, rashes, and discomfort.
- Device may detach prematurely due to adhesive issues.
- Concerns about billing practices and difficulty contacting customer service for billing inquiries.
- Mixed to negative reviews regarding management and leadership.
- Some employees report poor work-life balance, mandatory overtime, and micromanagement.
- Perceived negative shift in company culture over time.
Based on reviews from: Comparably, Indeed.com, Rannkly, Reddit, iRhythm (Official Website), Diagnostic and Interventional Cardiology, PMC (PubMed Central), YouTube, Better Business Bureau, GuruFocus
Last updated: 2026-07-19
Videos
News, demos, and interviews about iRhythm Technologies.
Videos load interactively. If none appear, search YouTube for iRhythm Technologies →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded iRhythm Technologies.
Related Companies
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]
Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]
The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]
Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]
Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]